June 16 (Reuters) - Intel on Tuesday said the new generation of its 18A manufacturing process has entered risk production, as ...

Intel is reportedly still struggling with a chipmaking process crucial to its future. Reuters reports that the company's 18A process is still producing low yields and high defect rates. Intel has ...

Advanced node manufacturing and heterogeneous integration require partnerships that span the full value chain.

deep dive Not long after rejoining Intel in 2021, former CEO Pat Gelsinger announced an ambitious plan to reinvent the chipmaker as a contract semiconductor manufacturing powerhouse.… Four years later ...

Intel Corp. is set to revamp its contract chip manufacturing business by pivoting away from its highly publicized 18A process and switching its attention to its next-generation 14A node in an effort ...

An Upstate technical college and a manufacturing facility are teaming up to create a job pipeline for recent grads and anyone ...

Forbes contributors publish independent expert analyses and insights. Mark C. Perna is a generational expert who covers education & careers. As parents, we give our kids lots of good advice. Don’t ...

As demand for CAR T therapies strain traditional manufacturing, Autolus Therapeutics has tapped Cellares to evaluate whether that company’s automated Cell Shuttle platform can support expanded ...

(Reuters) -Intel on Thursday unveiled key details of its upcoming Panther Lake laptop processor, the first chip built on its next-generation 18A production process, aiming to convince investors its ...

Intel is almost literally betting its future on its upcoming “Panther Lake” CPU architecture, as well as the 18A manufacturing process it will be built upon. While we don’t have any concrete details ...

Area adults seeking job training in high-growth manufacturing fields will soon have a free learning opportunity thanks to a $200,000 grant to Butler Tech’s adult education program. The first-time, ...

Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...